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Abstract 
 
Background: Diabetic cardiomyopathy (DCM) develop through oxidative stress-induced myocardial cell apoptosis that 
cause cardiac tissue damage resulting in hemodynamics disturbance while Cigarette Smoking (CS) is associated with a 
significant increase in the risk of recurrent ventricular tachyarrhythmia in ischemic and non-ischemic cardiomyopathy 
patients caused by oxidative stress. Curcuma longa extract (curcumin) is known to protect against hyperglycemia-induced 
oxidative stress. This brought in mind to investigate the probability of the crcumin ability to ameliorate the combined 
diabetes and smoking induced oxidative stress caused DCM   
Materials and Methods: Diabetic rats were administered nicotine to investigate the effect of the combined oxidative stress 
of diabetes and nicotine. Moreover, curcumin was administered to examine its protective effect on possible oxidative stress 
induced diabetes and nicotine. 
Results: Nicotine administration in a dose of 1.5 mg/kg to diabetic rats increased the oxidative stress. This occurs through 
elevation of plasma nitric oxide (NO) and upregulation of cardiac tissue inducible nitric oxide synthase (iNOS) and 
Endothelin-1 mRNA expressions, in addition to elevation of plasma triglycerides (TG), and LDL and reduction of HDL 
levels. Nicotine administration also reduced the cardiac tissue protective mechanism through reduction of plasma 
superoxide dismutase (SOD), cardiac tissue Erythropoietin (EPO), vascular endothelial growth factor (VEGF) isoforms and 
VEGF receptor mRNA expressions. These combined oxidative stresses were manifested by elevation of the plasma cardiac 
markers troponin I and creatine kinase (CK-MB).  Supplementation of curcumin prevented the diabetic and nicotine-
induced oxidative stress through reduction of plasma NO and iNOS and Endothelin-1 mRNA expressions to their control 
levels and elevation of plasma SOD and upregulation of cardiac tissue Erythropoietin (EPO), vascular endothelial growth 
factor (VEGF) isoforms and VEGF receptor mRNA expressions. This curcumin protective effect of the cardiac tissue was 
manifested by normalization of the plasma cardiac marker troponin I and CK-MB.  
Conclusion: These results strongly confirmed that curcumin protected cardiac tissues from the combined oxidative stress 
induced by diabetes and nicotine.  
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Introduction 
 
The most diabetic associated cardiovascular complication is cardiomyopathy that cause mortality in diabetic 
patients (Lu et al., 2015). Cardiomyopathy is characterized by myocardial structural and functional disorders. Incidence of 
diabetes is associated with oxidative stress (Baynes 1991) and is linked to heart failure that is manifested by contractile 
dysfunction (Neubauer 2007). In the diabetic heart, hyperglycemia increased the production of reactive oxygen species that 
impose oxidative stress. This lead to the development and progression of DCM (Cai et al 2006). Oxidative stress has been 
considered the determinant marker for severity of heart failure (Hare 2001). Diabetic cardiomyopathy may develop through  
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oxidative stress-induced myocardial cell apoptosis that cause cardiac tissue damage resulting in hemodynamics disturbance 
(Sawyer et al., 2002 and Giordano 2005). Smoking is associated with a significant increase in the risk of recurrent 
ventricular tachyarrhythmia in ischemic and non-ischemic cardiomyopathy patients (Plank et al., 2014). Smoking is the 
cause of independent risk factor of cardiovascular diseases that may increase myocardial infarction incidence (Bernhard and 
Wang 2007). Increased rate of apoptotic cell death (Csiszar et al., 2005) caused by oxidative stress in addition to 
endogenous protective mechanism perturbations (Ferdinandy et al., 2007) were suggested to have a considerable role in 
cardiovascular aging.  Vascular pathophysiology caused by cigarette smoking was suggested to be in part due to increased 
production of ROS (Csiszar et al., 2008). Cigarette smoking caused endothelial oxidative stress that results in NF-ЌB 
activation and proinflammatory alterations in vascular function (Orosz et al., 2007). Renal hemodynamics disturbances 
were induced by nicotine replacement therapy similar to smoking (Ritz et al., 1998). A major part of chronic nicotine-
induced intracellular ROS originates in the mitochondria (Arany et al., 2011). Through adversely affecting mitochondrial 
ROS production (Yang et al., 2007). The mechanism of chronic smoking-induced cardiovascular complications in diabetic 
patients still needs more elucidation especially at the molecular levels. The search for protection of the heart from such 
deleterious effect is continuous. Curcumin (a herbal extract) was reported to has anti-inflammatory effect through 
protecting the cellular component against reactive oxygen species (ROS) (Alison and Paul, 2000). Moreover, Curcumin has 
been demonstrated to have hepatoprotective effect against diethyl nitrosamine toxicity (Kadasa et al., 2015). More recently 
Curcumin intake was postulated to protect against coronary heart disease development through reducing oxidative damage 
and myocardium apoptosis (Liu et al., 2017). This motivates us to investigate the molecular mechanism of chronic 
administration of nicotine to streptozotocin induced diabetic rats and the possible protection against the combined oxidative 
stress of both diabetes and nicotine by curcumin. 
 
Material and Methods  
Animals 
 
Twenty-four adult-male Wistar rats weighting 190-220 grams (65-70 days old) were purchased from animal house 
of college of Pharmacy, King Saud University, KSA. Animals were kept at 22°C and 55% humidity in animal house center 
of Taif University, with 12-h light:12-h dark cycle. The rats were fed a standard pellet diet, and water ad libitum. The 
present work was approved by the ethical committee of Taif University to conduct the research project NO. 1/434/2799 
 
Formulation of animal food with the addition of curcumin 
 
Curcumin powder added to the animal foods in a rate of 1.5 gm/kg of food. The pellets were powdered and 
crushed then curcumin powder was mixed well. Then a small volume of water was added and the mix was made to a paste 
then reformed to pellets again. For 4 days, the pellets were left to dry in air. The rate of curcumin and nicotine 
concentration addition was added based on body weight of rats (200 gm). The average food consumption was estimated for 
one week was found to be about 25-30gm/day and 25ml/day for water consumption respectively. 
 
Experimental design 
 
Rats were adapted for 1 week then divided into two equal groups (6 rats per each) as follow. The 1st group used as 
a negative control (injected citrate buffer, pH 4.5). The 2nd group (18 rats) were fasted for 8 hrs, after which they were 
injected intraperitoneal with a single dose of 60 mg/kg of streptozotocin (Sigma Chemical Co., St. Louis, MO, USA), 
freshly dissolved in citrate buffer (pH 4.5). After injection, rats were given 5% glucose drink overnight to avoid 
hypoglycemic shock. After 3 days, the fasting blood glucose levels were determined from tail blood sample using 
glucometer (Accu-Chek Aviva BG meter; Roche Diagnostics, Indianapolis, IN).  Rats with glucose levels over 200 mg/100 
ml considered diabetic and used for next experiments and divided into diabetic group (6 rats), diabetic-nicotine group (DN, 
6 rats) supplied with nicotine (BDH. Chemicals LTD, Poole, England) in water (12 µg/ml to attain 1.5 mg/kg) and diabetic-
nicotine-curcumin group (DNC, 6 rats) diabetic rats supplied with nicotine as in DN plus curcumin (1.5 gm/kg). Treatments 
were continued for 8 weeks after induction of diabetes. Random blood glucose levels were measured every week to confirm 
diabetes incidence. At the end of the experiment, rats were fasted for 8 hrs and decapitated after inhalation of diethyl ether. 
Blood samples were collected from retro-orbital venous plexuses of rats on heparinized tubes to obtain plasma. Heart 
samples were taken for RNA extraction and kept at -80ºC until RT-PCR analysis. 
 
Biochemical analysis 
 
Kits for biochemical assessments were purchased from Human diagnostic (GmbH-56205 wiesbaden Germany). 
Plasma troponin I, nitrous oxide (NO), Cholesterol, TG and HDL and creatine kinase (CK) were measured using 
commercial kits (United Diagnostic Industry, UDI, Dammam, Saudi Arabia). Plasma levels of superoxide dismutase (SOD)  
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was measured using kits from Jiancheng Institute of Bioengineering Company, Nanjing, China. All measurements were 
carried out based on the instruction manual of each kit and suppliers. 
 
Analysis of gene expression 
 
 For preparation of total RNA, 50 mg of heart tissues were homogenized in 1ml QIAzol (QIAGEN Inc., Valencia, CA) 
and RNA was extracted as stated before (Alkedaide et al 2016). For cDNA synthesis, mixture of 2 µg of total RNA were 
denatured and reverse transcribed in a total volume of 20 µl as stated before (Alkedaide et al 2016). For Semi-quantitative 
Polymerase chain reaction (PCR), mRNA expression of some genes markers of heart damage and integrity were examined 
using corresponding specific primers (table 1). Of these examined genes, are erythropoietin (EPO), nitric oxide synthase 
(iNOS), vascular endothelial growth factor (VEGF) isoform (A), VEGF receptor 2  (VEGF R2) and endothelin-1. The used 
primers were synthesized by Macrogen (Macrogen Company, GAsa-dong, Geumcheon-gu. Korea). PCR was conducted as 
stated in our previous study (Alkediade et al 2016).  As a reference, expression of glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) mRNA was used. PCR products were run on gel 2 % agarose (Bio Basic INC. Konrad Cres, 
Markham Ontario) gel in TE (Tris-EDTA) buffer. The gel was stained with ethidium bromide. PCR products were 
photographed under UV light. The intensities of the bands were quantified using NIH image program 
(http://rsb.info.nih.gov/nih-image). 
 
                        Table 1: Primers and PCR conditions used for the tested genes. 
Gene 
Product size 
(bp) 
Annealing Temp. 
Direction 
(5'-3') 
Primer sequence 
G3PDH 309 52°C 
Sense AGATCCACAACGGATACATT 
Antisense TCCCTCAAGATTGTCAGCAA 
EPO 530 60°C 
Sense TACGTAGCCTCACTTCACTGCTT 
Antisense GCAGAAAGTATCCGCTGTGAGTGTTC 
iNOS 340 55°C 
Sense TCTGTGCCTTTGCTCATGAC 
Antisense CATGGTGAACACGTTCTTGG 
Endothelin-1 727 57.5°C 
Sense ATCATCTGGGTCAACACTC 
Antisense GAATCTCCTGGCTCTCTG 
VEGR 
isoforms 
514  
462  
330  
58°C 
Sense GACCCTGGTGGACATCTTCCAGGA 
Antisense GGTGAGAGGTCTAGTTCCCG 
VEGFR2 500  57°C 
Sense ACGGGGCAAGAGAAATGAAT 
Antisense GCAAAACACCAAAAGACCAC 
 
Statistical analysis 
 
 Data of current study were analyzed using analysis of variance (ANOVA) and Schefft's protected least-significant 
difference test using SPSS software (SPSS version13.0, IBM, Chicago, IL, USA) with P < 0.05 regarded as statistically 
significant. Results were expressed as means ± standard error (SE). 
 
Results 
Protective effect of curcumin on biochemical measurements related to cardiac activity  
 
 Plasma levels of troponin I, creatine kinase (CK-MB), TG and LDL were increased in diabetic rats than control and 
was further increased with nicotine administration while returned to nearly the normal control levels in the rats group 
administered curcumin.  Plasma NO was increased in diabetic rats compared to control and reduced in the diabetic rats 
administered nicotine and further reduced in the diabetic nicotine rats administered curcumin. SOD was found to be 
significantly decreased in diabetic rats compared to control which could be due to oxidative stress induced by diabetes. 
Reduction of this antioxidant enzyme levels became more severe in diabetic rats treated by nicotine and improved by 
curcumin supplementation (Tables 2).  
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Table 2: Plasma changes in biochemical parameters related to cardiac activity during diabetes and after administration of 
nicotine and/or curcumin.  
Values are represented as means ± SE for four rats. Values with symbol * are significantly at P<0.05 relative to control. 
Values with symbol # are significantly at P<0.05 relative to D. Values with symbol $ are significantly at P<0.05 relative to 
DN.  
 
Protective effect of curcumin on cardiac Erythropoietin (EPO) and iNOS mRNA expression    
 
In the cardiac muscle the mRNA expression levels of EPO show reduction in diabetic rats and in diabetic rats 
administered nicotine while curcumin administration to diabetic nicotine rats caused EPO mRNA expression to increase 
even higher than control rats (Figure 1A). The levels of cardiac tissues iNOS mRNA expression was increased only in the 
diabetic rats administered nicotine while curcumin supplementation to rats group administered nicotine reduced the iNOS 
expression nearly to the control levels (Figure 1B). 
 
Figure 1: Protective Effect of curcumin on mRNA expression of EPO and iNOS in Cardiac tissues: Total RNA was 
extracted from heart tissues and the expressions of Erythropoietin (EPO) (A) inducible nitric oxide synthase (iNOS) (B) 
were semi-quantified by using RT-PCR. Values are means ± SE of 6 rats. *p < 0.05 Vs Control rats, §* p < 0.05 Vs 
diabetic rats, # p < 0.05 Vs DN treated rats. The treatment groups are: Control (CNT) Diabetes (D), Diabetes and nicotine 
(DN) and diabetes plus nicotine plus curcumin (DNC).  
 
 
 
 
 
Parameter Control Diabetes (D) Diabetes + Nicotine (DN 
Diabetes + Nicotine + 
Curcumin (DNC) 
Troponin I (ng/ml) 0.6 ± 0.06 0.8 ± 0.02* 1.1 ± 0.03# 0.43 ± 0.08 $ 
CK MB (ng/ml) 2.7±0.2 3.32± 0.03* 5.8±0.04# 3.7±0.18$ 
TG  (mg/dL) 52.3 +8 63.3 ±12.5
*
 81.7+4.5 
#
 61.7±14
$
 
LDL (mg/dL) 504.8±12.5 640.8±8.4* 882.8±34# 589 ± 22$ 
HDL  (mg/dL) 18.7±1.2 15.3±0.5 11.3±1.2 # 21± 0.9 $ 
NO  (µmol/L) 22.7±1.7 62 ± 4.7* 39±0.7 # 28.7± 0.3 $ 
SOD  (U/mL) 11.67 ± 0.16 7.94± 0.17* 5.80 ± 2# 10.73±0.3$ 
GPx U/ml 115.67 + 3.8 85.67 + 3.3* 69 + 0.7 # 105.3 + 9. $ 
MDA (nmol/ml) 3 +0.8 4.4 + 2.1* 8.74+ 1.2 # 3.63+ 0.16 $ 
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Protective effect of curcumin on cardiac VEGF isoform and VEGF Receptor mRNA expression    
 
  In the cardiac muscle, the mRNA expression levels of VEGF isoform were decreased in diabetic rats and further 
decreased in diabetic rats administered nicotine.  While in the diabetic rat groups supplemented with curcumin in addition 
to nicotine, the VEGF isoforms mRNA expression was increased even than control levels (Fig.2A). We further measured 
the VEGF receptor in the cardiac muscle that show reduction in the diabetic rats and further reduction in the diabetic rats 
administered nicotine while curcumin supplementation prevented this reduction and increased its expression even than 
control levels (Fig 2B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Effect of curcumin on mRNA expression of VEGF isoforms and VEGF receptor 2 in Cardiac tissues: Total RNA 
was extracted from heart tissues and the expressions of vascular endothelial growth factor (VEGF) (A), VEGF receptor 2 
(VEGF R2) (B) were semi-quantified using RT-PCR. Values are means ± SE of 6 rats. *p < 0.05 Vs Control group, §* p < 
0.05 Vs diabetic rats, # p < 0.05 Vs DN treated rats. The treatment groups are: Control (CNT) Diabetes (D), Diabetes and 
nicotine (DN) and diabetes plus nicotine plus curcumin (DNC).  
 
Protective effect of curcumin on cardiac Endothelin-1 mRNA expression 
 
In the cardiac muscle, the mRNA expression levels of endothelin-1 was decreased in diabetic rats than control and 
highly induced in the diabetic rats administered with nicotine while curcumin administration to diabetic nicotine rats caused 
endothelin-1 mRNA expression to return nearly to the control expression levels (Figure 3A). 
 
 
 
 
 
 
 
 
 
 
 
 
69 
 
   Figure 3: Effect of curcumin on mRNA expression of endothelin-1 (ET-1) in Cardiac tissues: Total RNA was extracted 
from heart tissues and the expressions of ET-1 was semi-quantified using RT-PCR analysis. Values are means ± SE of 6 
rats. *p < 0.05 Vs Control group, §* p < 0.05 Vs diabetic group, # p < 0.05 Vs DN treated rats. The treatment groups are 
Control (CNT) Diabetes (D), Diabetes and nicotine (DN) and diabetes plus nicotine plus curcumin (DNC). 
 
Discussion 
 
The current study confirmed protective effect of curcumin against oxidative stress induced by diabetes and 
nicotine. As known, hyperglycemia is accompanied by an increase in production of ROS that impose oxidative stress and 
plays a role in the pathogenesis of DCM (Cai et al., 2006). In the current study, the combined damaging effect of diabetes 
and nicotine on the cardiac muscle may operate through inducing oxidative stress through increasing nitric oxide 
production (table 2) through inducing iNOS mRNA expression (Fig.1 B) and decreasing the scavenging and protective 
mechanism through decreasing SOD (table 2) and downregulation of EPO expression levels (Fig.1 A). Superoxide 
overproduction in the cellular systems is a marker for diabetic cardiomyopathy (Kain et al., 2011). SOD enhances 
dismutation of superoxide radicals (Moussa 2008). The reduction of SOD in diabetic rats in our study and other (Badole et 
al., 2015), imply that diabetic oxidative stress operates through SOD reduction. Indeed, inability of the different body 
antioxidant mechanism to scavenge reactive oxygen species (ROS) due to overproduction and/or reduction of the body anti-
oxidant defense mechanisms lead to oxidative stress.   
Erythropoietin exerts a cardio-protective effect against infarction and ischemia-reperfusion injury (Calvillo et al 
2003; Moon et al., 2003). The downregulation of EPO expression in the cardiac tissue by diabetes and nicotine may imply 
that they exert their oxidative stress through reducing the cardiac muscle protective mechanism. This oxidative stress 
exerted by diabetes and nicotine on the cardiac tissue may be the cause in the elevation of plasma creatine kinase (CK-MB) 
and Troponin I (table 2). Diabetic animals showed increased levels of (CK-MB) as reported by Edet et al (2009) and our 
findings. Diabetes enhanced the expression of the cardiac damage markers like troponin I (Kain et al., 2011). When cardiac 
damage occurs, cardiac myocyte release troponin into circulation (Hassan et al., 2009). In our study diabetes, increased 
plasma troponin that was further increased with nicotine administration (table 2).  
The addition of curcumin protected the cardiac muscle from the damaging effect of diabetes and nicotine. This 
curcumin protection is manifested by reducing the oxidative stress through reducing the NO production and down 
regulation of the iNOS mRNA expression. It also protects the heart from the diabetes and nicotine-oxidative stress through 
the increase in plasma SOD and upregulation of EPO mRNA expression and normalization of diabetes and nicotine 
elevated LDH, TG, normalization of the diabetes and nicotine-reduced plasma HDL. EPO production is primarily 
stimulated by hypoxia that increases serum EPO levels up to several hundred-fold depending on severity of hypoxia (Ebert 
and Bunn 1999). hypoxia response element (HRE) was demonstrated in the 3′- flanking region of the human EPO gene 
(Semenza et al., 1991) hypoxia-inducible factors (HIFs), are the master transcription factors for oxygen-dependent EPO 
gene regulation (Franke et al., 2013) HIF-1α mRNA levels increase dramatically in response to hypoxia or ischemia in 
heart (Lee et al., 2000) . Hydroxylation and subsequent ubiquitination of HIF-1a is suppressed under hypoxic conditions, 
resulting in HIF-1a protein accumulation without changes in HIF-1a mRNA levels (Stockmann and Fandrey 2017).  
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Hyperglycemia was demonstrated to enhance production of methylglyoxal (MGO) that was recently reported to enhance 
the degradation of HIF-1α protein (Ramalho et al., 2017) this may explain EPO downregulation in diabetic rats in our study 
due to diabetes induced degradation of HIF. Moreover, Nanocurcumin ameliorated hypoxia-induced hypertrophy and 
apoptosis in H9c2 cells by stabilizing HIF-1α protein and accumulation (Nehra et al., 2015). This could be the mechanism 
through which curcumin induces EPO expression in the current study. 
 This protective effect is manifested by normalization of the diabetes and nicotine-induced plasma CK-MB and 
Troponin I. VEGF is well known for its ability to stimulate proliferation of endothelial cells in vitro and neovasculogenesis 
in the ischemic heart in vivo (Zisa et al., 2009; Gao et al., 2007). The down regulation of the VEGF isoforms and VEGF 
receptor mRNA expression by diabetes and nicotine may be one of the pathway through which they stressed the cardiac 
muscle. Curcumin upregulated mRNA expression of the VEGF isoforms and VEGF receptor could be a pathway through 
which curcumin protect the cardiac muscle from the combined oxidative stress exerted by diabetes and nicotine.  
During myocardial experience ischemia and reperfusion endothelin levels are significantly increased in the 
coronary and the ischemic area tissues (Ling et al., 2014). The diabetes plus nicotine-induced endothelin mRNA in the 
cardiac tissue indicates that their combined oxidative stress may increase the probability of ischemic area in the cardiac 
tissues. However, the addition of curcumin nearly normalized the induced endothelin-1 mRNA expression caused by 
nicotine and diabetes which indicates the protective effect of curcumin against the diabetes and nicotine oxidative stress. 
 
Conclusion 
 
The current study confirmed that both diabetes and nicotine showed combined oxidative stress on the cardiac 
tissues through increasing in ROS production, NO production, and upregulation of cardiac tissue iNOS mRNA expression 
diabetes and nicotine decreased the protective mechanism through decreasing plasma SOD and EPO mRNA expression in 
cardiac muscle. They increased the main cardiac biomarkers (Troponin and CK-MB). These deleterious effects were 
ameliorated by curcumin administration. Curcumin protects cardiac tissues from oxidative stress through normalization of 
troponin and creatine kinase cardiac biomarkers. 
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